Bridged heterocyclic compounds and methods of use

摘要

This disclosure relates to new compounds that may be used to modulate a histamine receptor in an individual. Novel compounds are described, including new bridged heterocyclic[4,3-b]indole compounds. Pharmaceutical compositions are also provided. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.

主权项

1. A compound, or a salt thereof, wherein the compound is selected from the group consisting of compounds:Compound #Structure115116117119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155163164165